ID

21388

Descrizione

NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: ABC-Containing Product Discontinuation Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Keywords

versioni (1)
  1. 19/04/17 19/04/17 -
Caricato su

19 aprile 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Genetic Screening For HLA-B*5701 in Patients with HIV ABC-Containing Product Discontinuation NCT00340080

Inglese

Genetic Screening For HLA-B*5701 ABC-Containing Product Discontinuation NCT00340080

1 moduli  
ABC-Containing Product Discontinuation
Descrizione

ABC-Containing Product Discontinuation

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0663655
UMLS CUI-3
C0850893
Subject Identifier
Descrizione

Subject Identifier

Tipo di dati

text

Alias
UMLS CUI [1]
C2348585
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Ziagen:
Descrizione

Ziagen stopped

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0724476
UMLS CUI [1,2]
C0850893
Primary reason the ABC-Containing Product was stopped, Ziagen:
Descrizione

If Yes, 􏰀check the primary reason the ABC-Containing Product was stopped

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0724476
Primary reason the ABC-Containing Product was stopped, Ziagen:
Descrizione

If Other, please specify

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0724476
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Trizivir:
Descrizione

Trizivir stopped

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0939514
UMLS CUI [1,2]
C0850893
Primary reason the ABC-Containing Product was stopped, Trizivir:
Descrizione

primary reason Trizivir was stopped

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0939514
Primary reason the ABC-Containing Product was stopped, Trizivir:
Descrizione

If Other, please specify

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0939514
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Kivexa:
Descrizione

Kivexa stopped

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1567988
UMLS CUI [1,2]
C0850893
Primary reason the ABC-Containing Product was stopped, Kivexa:
Descrizione

primary reason Kivexa was stopped

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C1567988
Primary reason the ABC-Containing Product was stopped, Kivexa:
Descrizione

If Other, please specify

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C1567988
Ritorna all'inizio della pagina

Similar models

Genetic Screening For HLA-B*5701 ABC-Containing Product Discontinuation NCT00340080

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
ABC-Containing Product Discontinuation
C0013227 (UMLS CUI-1)
C0663655 (UMLS CUI-2)
C0850893 (UMLS CUI-3)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Ziagen:
text
C0724476 (UMLS CUI [1,1])
C0850893 (UMLS CUI [1,2])
ABC-Containing product stopped
Code List
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Ziagen:
CL Item
Yes (Y)
CL Item
No (N)
Item
Primary reason the ABC-Containing Product was stopped, Ziagen:
integer
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
primary reason the ABC-Containing Product was stopped
Code List
Primary reason the ABC-Containing Product was stopped, Ziagen:
CL Item
Adverse event (Record details on the Non-Serious Adverse Events or Serious Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Investigator Decision (26)
CL Item
Other, specify (0)
primary reason Ziagen was stopped
Item
Primary reason the ABC-Containing Product was stopped, Ziagen:
text
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
Item
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Trizivir:
text
C0939514 (UMLS CUI [1,1])
C0850893 (UMLS CUI [1,2])
ABC-Containing product stopped
Code List
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Trizivir:
CL Item
Yes (Y)
CL Item
No (N)
Item
Primary reason the ABC-Containing Product was stopped, Trizivir:
integer
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
primary reason the ABC-Containing Product was stopped
Code List
Primary reason the ABC-Containing Product was stopped, Trizivir:
CL Item
Adverse event (Record details on the Non-Serious Adverse Events or Serious Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Investigator Decision (26)
CL Item
Other, specify (0)
primary reason Trizivir was stopped
Item
Primary reason the ABC-Containing Product was stopped, Trizivir:
text
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
Item
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Kivexa:
text
C1567988 (UMLS CUI [1,1])
C0850893 (UMLS CUI [1,2])
ABC-Containing product stopped
Code List
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Kivexa:
CL Item
Yes (Y)
CL Item
No (N)
Item
Primary reason the ABC-Containing Product was stopped, Kivexa:
integer
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
primary reason the ABC-Containing Product was stopped
Code List
Primary reason the ABC-Containing Product was stopped, Kivexa:
CL Item
Adverse event (Record details on the Non-Serious Adverse Events or Serious Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Investigator Decision (26)
CL Item
Other, specify (0)
primary reason Kivexa was stopped
Item
Primary reason the ABC-Containing Product was stopped, Kivexa:
text
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial